Sign inJoin waitlistJoin the waitlist

IS

Imad Shureiqi

Physician · University of Michigan Health-Ann Arbor

Credentials: · · · ·

History

University of Michigan Health-Ann Arbor
2021–Present

Medical Oncology
1988–1990
Internal Medicine
1985–1988
Doctor of Medicine
1981–1985

Research

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
Genome Research · 2013 · 524 citations
Fusobacterium in colonic flora and molecular features of colorectal carcinoma
Cancer Research · 2014 · 385 citations
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer
Journal of Clinical Oncology · 2001 · 256 citations

Scott Lippman
16 papers · 1 as a resident
Scott Kopetz
14 papers
Michael Overman
11 papers · 1 as a fellow
Cathy Eng
10 papers
Bryan Kee
9 papers
DF
David Fogelman
9 papers
Robert Wolff
9 papers
Russell Broaddus
9 papers
Kanwal Raghav
8 papers
Van Morris
8 papers
Arvind Dasari
7 papers
DB
Dean Brenner
7 papers

Grants

PPARD Hyperactivation Promotes Pancreatic Intraepithelial Neoplasia Progression into Pancreatic Ductal Adenocarcinoma
National Cancer Institute · R01
Contact PI · $1.9M · University of Michigan at Ann Arbor
2024–2029
ALOX15 Regulation of Colon Cancer Invasiveness via PI3P-Linoleic Acid Metabolism
National Cancer Institute · R01
Contact PI · $3.2M · University of Michigan at Ann Arbor
2022–2027
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
National Cancer Institute · R01
Contact PI · $1.8M · University of Michigan at Ann Arbor
2016–2022
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
National Cancer Institute · R01
Contact PI · $1.8M · University of Michigan at Ann Arbor
2016–2021

Clinical trials

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2003–2021